Oxymetazoline nasal spray (sold as Afrin, Dristan, and similar brands) is not clearly proven harmful during pregnancy, but it carries enough uncertainty that most providers recommend trying safer options first. The limited research available is somewhat reassuring for occasional use, though the evidence is far from complete.
What the Research Shows
A small study measured blood flow in the uterine artery, fetal aorta, and umbilical artery after giving pregnant women a single dose of intranasal oxymetazoline. Blood flow velocities did not change significantly from baseline in any of these locations. In no case did blood flow drop to worrisome levels. For uncomplicated pregnancies, the researchers concluded there were no significant acute changes in maternal or fetal circulation from a single dose.
That’s encouraging, but it only tells us about short-term blood flow effects from one dose. The bigger concern is whether repeated use during critical developmental windows could affect the baby. A large epidemiological study published in the American Journal of Epidemiology looked at birth defects among women who used decongestants in early pregnancy. Among over 7,600 women without affected pregnancies, about 66 reported using oxymetazoline in the first trimester. Researchers found small numbers of cases involving heart defects, cleft lip, and pyloric stenosis (a stomach condition in newborns) among oxymetazoline-exposed pregnancies, but none of these associations reached statistical significance. The numbers were too small to draw firm conclusions either way.
One finding did stand out: second-trimester oxymetazoline use was associated with a roughly threefold increase in kidney collecting system anomalies in the baby. That association was statistically significant, though it was based on a small number of cases and hasn’t been confirmed by other studies. It’s the kind of signal that makes researchers and clinicians cautious without being definitive proof of harm.
Why Providers Urge Caution
Oxymetazoline works by constricting blood vessels in the nasal passages. That’s what clears your congestion so quickly. The concern during pregnancy is that this vasoconstriction could theoretically extend beyond your nose, potentially affecting blood flow to the uterus or placenta. The Doppler study mentioned above suggests this doesn’t happen to a measurable degree with a single dose, but no one has studied what happens with repeated daily use over several days or weeks.
There’s also the rebound congestion problem, which matters more during pregnancy than at other times. If you use oxymetazoline for more than three consecutive days, your nasal passages can become even more swollen than they were before you started the spray. This is called rhinitis medicamentosa, and it can trap you in a cycle of needing the spray to breathe normally. During pregnancy, when many women already deal with chronic nasal stuffiness from hormonal swelling, this rebound effect can make things significantly worse and harder to treat.
If You Do Use It
If your congestion is severe and nothing else has helped, a short course of oxymetazoline is unlikely to cause harm based on available evidence. The standard dosing is two or three sprays of the 0.05% solution in each nostril every 10 to 12 hours, no more than twice in 24 hours, and for no longer than three days. Sticking to this limit is important both for avoiding rebound congestion and for minimizing any systemic absorption.
The product label does not carry a specific pregnancy warning the way some medications do, but it also lacks adequate studies confirming safety. This puts it in a gray zone where occasional, short-term use is generally considered low risk, but routine use is not recommended.
Safer Options for Nasal Congestion
Pregnancy rhinitis, the chronic stuffiness that affects roughly one in five pregnant women, responds well to several treatments that carry no known risks.
- Saline nasal rinses: A neti pot or squeeze bottle with saline solution physically flushes out mucus and reduces swelling without any medication. This is the most universally recommended first step.
- Corticosteroid nasal sprays: Products like fluticasone (Flonase) and triamcinolone (Nasacort) are considered safe during pregnancy. They reduce inflammation in the nasal passages and, unlike oxymetazoline, can be used long-term without rebound congestion.
- Elevating your head while sleeping: Propping yourself up slightly helps reduce blood pooling in the nasal tissues overnight, which is when pregnancy congestion tends to be worst.
- Exercise: Physical activity improves blood flow and can temporarily reduce nasal swelling. Even a brisk walk often provides noticeable relief.
- Staying hydrated: Drinking plenty of water helps thin nasal mucus, making it easier to clear.
For most pregnant women, a combination of saline rinses and a corticosteroid spray will control congestion effectively enough that oxymetazoline isn’t needed. If those approaches aren’t cutting it and you’re losing sleep or struggling to breathe comfortably, a one- or two-day course of oxymetazoline is a reasonable option to discuss with your provider, keeping in mind the three-day maximum.